Silexion Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2013	FY 2012
Period Ending	Nov '24 Nov 14, 2024	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Quick Ratio	3.64	3.64	10.47
Current Ratio	3.85	3.85	10.64
Return on Equity (ROE)	-116.66%	-116.66%	-
Return on Assets (ROA)	-62.13%	-62.13%	-
Return on Capital (ROIC)	-73.07%	-73.07%	-
Buyback Yield / Dilution	-16.10%	-
Total Shareholder Return	-16.10%	-

Source: S&P Capital IQ. Standard template. Financial Sources.